SLC6A3 and Parkinson disease: Deficits in the DS, assessed primarily with dopamine transporter (DAT) SPECT imaging, have been associated with decreased global12, 13 and specific14, 15, 16 cognitive abilities in preliminary studies, including in early PD.17, 18, 19